SEARCH

SEARCH BY CITATION

References

  • Advokat, C. & Rhein, F.Q. (1995). Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res., 699, 157160.
  • Antonijevic, I., Mousa, S.A., Schafer, M. & Stein, C. (1995). Perineural defect and peripheral opioid analgesia in inflammation. J. Neurosci., 15, 165172.
  • Bilsky, E.J., Inturrisi, C.E., Sadée, W., Hruby, V.J. & Porreca, F. (1996). Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain, 68, 229237.
  • Broussard, D.L., Li, X., Pritchett, D.B., Lynch, D., Bannermann, G.C. & Pleasure, D. (1994). The expression of a NMDA receptor gene in guinea-pig myenteric plexus. NeuroReport, 5, 973976.
  • Brown, N.J., Coupar, I.M. & Rumsey, R.D.E. (1988). The effect of acute and chronic administration of morphine and morphine withdrawal on intestinal transit time in the rat. J. Pharm. Pharmacol., 40, 844848.
  • Buzas, B., Rosenberger, J. & Cox, B.M. (1996). μ and δ opioid receptor gene expression after chronic treatment with opioid agonist. NeuroReport, 7, 15051508.
  • Campbell, B.G., Couceyro, P., Keana, J.F.W. & Weber, E. (1991). N-methyl-D-aspartate receptor-mediated contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation: modulation by phencyclidine and glycine receptors. J. Pharmacol. Exp. Ther., 257, 754766.
  • D'amato, M., Stamford, I.F. & Bennett, A. (1991). Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileium. Br. J. Pharmacol., 102, 391395.
  • Dierssen, M., Florez, J. & Hurle, M.A. (1990). Calcium channel modulation by dihydropyridine modifies sulfentanil-induced antinociception in acute and tolerant conditions. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 559565.
  • Dunbar, S. & Yaksh, T.L. (1996). Concurrent spinal infusion of MK-801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology, 84, 11771188.
  • Foley, K.M. (1991). Clinical tolerance to opioids. In Towards a New Pharmacotherapy of Pain. pp. 181203. Chichester: John Wiley & Sons.
  • Halley, T.J. & Mccornick, W.G. (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mice. Br. J. Pharmacol. Chemother., 12, 1215.
  • Han, J.S. (1995). Cholecystokinin octapeptide (CCK-8): a negative feedback control mechanism for opioid analgesia. In Progress in Brain Research. ed. Yu, A., Eng, L., McMahan, V., Shulman, H., Shooter, S. & Stadlin, A.. pp. 263271, China: Elsevier Science BV.
  • Jaffe, J.H. (1990). Drug addiction and drug abuse. In The Pharmacological Basis of Therapeutics. ed. Goodman, A., Rall, T.W., Nies, A.S. & Taylor, P.. pp. 522573, New York: Pergamon Press.
  • Kellstein, D.E. & Mayer, D.J. (1991). Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance. Pain, 47, 221229.
  • Makovec, F., Bani, M., Cereda, R., Chiste, R., Pacini, M.A., Revel, L., Rovati, L.C. & Setnikar, I. (1987). Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Arzneimittelforschung, 37, 12651268.
  • Meyer, B.M., Werth, B.A., Beglinger, C., Hildebrand, P., Jansen, J.B., Zach, D., Rovati, L.C. & Stadler, G.A. (1989) Role of cholecystokinin regulation of gastrointestinal motor functions. Lancet, 2, 1215.
  • Neil, A., Kayser, V., Chen, Y.L. & Guilbaud, G. (1990). Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy. Brain Res., 552, 140143.
  • Nestler, E.J. (1992). Molecular mechanisms of drug addiction. J. Neurosci., 12, 24392450.
  • Pol, O., Ferrer, I. & Puig, M.M. (1994). Diarrhea associated with intestinal inflammation increases the potency of μ and δ opioids on the inhibition of gastrointestinal transit in mice. J. Pharmacol. Exp. Ther., 270, 386391.
  • Pol, O., Planas, E. & Puig, M.M. (1995). Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation. J. Pharmacol. Exp. Ther., 272, 12711276.
  • Pol, O., Planas, E. & Puig, M.M. (1996a). Effects of morphine and liposomal morphine in a model of intestinal inflammation in mice. Pharmacology, 53, 180189.
  • Pol, O., Sanchez, B. & Puig, M.M. (1996b). Peripheral effects of opioids in a model of intestinal inflammation in mice. Pharmacology, 53, 340350.
  • Pol, O., Valle, L.L., Ferrer, I. & Puig, M.M. (1996c). The inhibitory effects of α2-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation. Br. J. Pharmacol., 119, 16491655.
  • Puig, M.M., Pol, O. & Warner, W. (1996). Interaction of morphine and clonidine on gastrointestinal transit in mice. Anesthesiology, 85, 14031412.
  • Roerig, S.C. (1995). Decreased spinal morphine/clonidine antinociception synergism in morphine-tolerant mice. Life Sci., 56, 115122.
  • Selley, D.E., Breivogel, C.S. & Childers, S.R. (1993). Modification of opioid receptor-G-protein function by low pH pretreatment of membranes from NG108–15 cells: Increase in opioid agonist efficacy by decreased inactivation of G-proteins. Mol. Pharmacol., 44, 731741.
  • Shook, J.E., Pelton, J.T., Hruby, V.J. & Burks, T.F. (1987). Peptide opioid antagonists separate peripheral and central opioid antitransit effects. J. Pharmacol. Exp. Ther., 243, 492500.
  • Stein, C., Pflüger, M., Yassouridis, A., Hoelzl, J., Lehrberger, K., Welte, C. & Hassan, A.H.S. (1996). No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest., 98, 793799.
  • Tallarida, R.J. & Murray, R.B. (1986). Manual of Pharmacologic Calculations with Computer Programs New York: Springer-Verlag.
  • Tao, P.L., Lee, C.R., Law, P.Y. & Loh, H.H. (1993). The interaction of the μ-opioid receptor and G protein is altered after chronic morphine treatment in rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 504508.
  • Trujillo, K.A. & Akil, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 8587.
  • Trujillo, K.A. & Akil, H. (1994). Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res., 633, 178188.
  • Van Der Bent, A., Ijzerman, A.P. & Soudijn, W. (1994). Molecular-modelling of CCK-A receptors. Drug Des. Discov., 12, 129148.
  • Wong, C.L., Roberts, M.B. & Wai, M.K. (1980). Effect of morphine and naloxone on intestinal transit in mice. Eur. J. Pharmacol., 64, 289295.
  • Woodruff, G.N., Foster, A.C., Gill, R., Kemp, J.A., Wong, E.H. & Iversen, L.L. (1987). The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology, 26, 903909.
  • Xu, X.J., Wiesenfeld-Hallin, Z., Hughes, J., Horwell, D.C. & Hokfelt, T.C. (1992). A selective antagonist of cholecystokinin-B receptors, prevents morphine tolerance in the rat. Br. J. Pharmacol., 105, 591596.
  • Zadina, J.E., Kastin, A.J., Harrison, L.M., Ge, L.J. & Chang, S.L. (1995) Opiate receptor changes after chronic exposure to agonists and antagonists. Ann. New York Acad. Sci., 757, 353361.
  • Zhou, Y., Sun, Y.H., Zhang, Z.W. & Han, J.S. (1992). Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine. NeuroReport, 3, 11211123.